Scientists had long assumed that any genetic mutation that does not alter a protein sequence should have no impact on human health. But recent research has shown that such synonymous DNA changes can trigger disease in a number of ways. Alla Katsnelson talks to scientists and biotech companies who are speaking up about 'silent' mutations.
This is a preview of subscription content, log in via an institution to check access.
References
Kimchi-Sarfaty, C. et al. Science 315, 525–528 (2007).
Nackley, A.G. et al. Science 314, 1930–1933 (2006).
Chen, R., Davydov, E.V., Sirota, M. & Butte, A.J. PLoS ONE 5, e13574 (2010).
Parmley, J.L., Chamary, J.V. & Hurst, L.D. Mol. Biol. Evol. 23, 301–309 (2006).
Sauna, Z.E. & Kimchi-Sarfaty, C. Nat. Rev. Genet. 12, 683–691 (2011).
Brest, P. et al. Nat. Genet. 43, 242–245 (2011).
Bartoszewski, R.A. et al. J Biol. Chem. 285, 28741–28748 (2010).
Kudla, G., Murray, A.W., Tollervey, D. & Plotkin, J.B. Science, 324, 255–258 (2009).
Itakura, K. et al. Science 198, 1056–1063 (1977).
Welch, M. et al. PLoS ONE 4, e7002 (2009).
Fath, S. et al. PLoS ONE 6, e17596 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katsnelson, A. Breaking the silence. Nat Med 17, 1536–1538 (2011). https://doi.org/10.1038/nm1211-1536
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1211-1536
- Springer Nature America, Inc.
This article is cited by
-
Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations
BioDrugs (2018)
-
Computational approaches to study the effects of small genomic variations
Journal of Molecular Modeling (2015)
-
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
Diabetologia (2012)